NCT04967625 2021-07-28
A Phase II Study of Sintilimab Combined With Anlotinib in Treatment of ED-SCLC
Zhejiang Cancer Hospital
Phase 2 Unknown
Clinical Trials
3 trialsNCT03755115 2019-01-16
SHR-1210 Combined With Epirubicin in the Treatment of Extensive Disease Small Cell Lung Cancer
Henan Cancer Hospital
Phase 2 Unknown
NCT02179528 2014-09-12
Study of Small Doses of Etoposide as Maintenance Treatment in Small Cell Lung Cancer(SCLC)
Peking University Cancer Hospital & Institute
Phase 2 Unknown